The North America sequencing reagents market is estimated to record a CAGR of 12.69% during the forecast period, 2021-2028. The market growth is accredited to the growing demand for gene synthetic techniques from biotechnology and biopharmaceutical companies.
NORTH AMERICA SEQUENCING REAGENTS MARKET FORECAST 2021-2028
North America Sequencing Reagents Market by Technology (Next-generation Sequencing, Sanger Sequencing, Third-generation Sequencing) Market by Reagent Type (Sequencing Kits, Control Kits, Library Kits, Template Kits, Other Reagent Types) Market by Application (Oncology, Clinical Investigation, Agri Genomics and Forensics, Reproductive Health, Other Applications) Market by End-user (Research Institutes, Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End-users) by Geography
The North America sequencing reagents market is estimated to record a CAGR of 12.69% during the forecast period, 2021-2028. The market growth is accredited to the growing demand for gene synthetic techniques from biotechnology and biopharmaceutical companies.
To learn more about this report, request a free sample copy
The North America sequencing reagents market growth assessment includes the analysis of Canada and the United States. There is a rising demand from US-based pharmaceutical and biotechnology companies for genomics technology, which is set to propel market growth. Also, US-based organizations are taking significant steps like scaling up gene synthesis. This essential method enhances gene therapy’s fidelity, which is done through techniques like microfluidics application and multiplexing. In addition, several new players are building synthetic DNA platforms due to their high potential abilities in various medical and clinical sectors.
Furthermore, the pandemic has offered ample growth opportunities in the genomics segment of biotechnology. Also, genomic applications like SARS-CoV-2 virus surveillance are on the rise. At the same time, genomics is in demand for scientific research in key areas like oncology and microbiology.
TriLink Biotechnologies is a biotechnology company that manufactures and distributes mRNA transcripts, custom chemistry, nucleotides, oligonucleotides, etc. The company focuses on the diagnostic, vaccine, biopharmaceutical, and therapeutic solutions by providing innovative biotechnological products. It has distributors globally, with headquarters in San Diego.
To request a free sample copy of this report, please complete the form below:
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.
- RESEARCH SCOPE & METHODOLOGY
- STUDY OBJECTIVES
- SCOPE OF STUDY
- METHODOLOGY
- ASSUMPTIONS & LIMITATIONS
- EXECUTIVE SUMMARY
- MARKET SIZE & ESTIMATES
- MARKET OVERVIEW
- MARKET DYNAMICS
- KEY DRIVERS
- ADVANCED SEQUENCING METHODS LOWER THE COST OF SEQUENCING PROCEDURES
- CONTINUOUS FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
- PREVALENCE OF CHRONIC DISEASES
- KEY RESTRAINTS
- LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE
- SOCIAL AND ETHICAL ISSUES RELATED TO THE DATA PRIVACY
- KEY DRIVERS
- KEY ANALYTICS
- IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
- KEY MARKET TRENDS
- PORTER’S FIVE FORCES ANALYSIS
- BUYERS POWER
- SUPPLIERS POWER
- SUBSTITUTION
- NEW ENTRY
- INDUSTRY RIVALRY
- SUPPLY CHAIN ANALYSIS
- OPPORTUNITY MATRIX
- VENDOR LANDSCAPE
- MARKET BY TECHNOLOGY
- NEXT-GENERATION SEQUENCING
- SANGER SEQUENCING
- THIRD-GENERATION SEQUENCING
- MARKET BY REAGENT TYPE
- SEQUENCING KITS
- CONTROL KITS
- LIBRARY KITS
- TEMPLATE KITS
- OTHER REAGENT TYPES
- MARKET BY APPLICATION
- ONCOLOGY
- CLINICAL INVESTIGATION
- AGRI GENOMICS AND FORENSICS
- REPRODUCTIVE HEALTH
- OTHER APPLICATIONS
- MARKET BY END-USER
- RESEARCH INSTITUTES
- HOSPITALS AND CLINICS
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- OTHER END-USERS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGES
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- KEY STRATEGIC DEVELOPMENTS
- MERGERS & ACQUISITIONS
- PRODUCT LAUNCHES & DEVELOPMENTS
- PARTNERSHIPS & AGREEMENTS
- BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
- COMPANY PROFILES
- AGILENT TECHNOLOGIES INC
- ASURAGEN INC
- BGI GENOMICS
- BIO-RAD LABORATORIES INC
- HOFFMANN-LA ROCHE
- FLUIDIGM CORPORATION
- ILLUMINA INC
- LGC BIOSEARCH TECHNOLOGIES
- MERCK KGAA
- PACIFIC BIOSCIENCES OF CALIFORNIA INC
- PERKINELMER INC
- QIAGEN NV
- TAKARA BIO INC
- THERMO FISHER SCIENTIFIC INC
- TRILINK BIOTECHNOLOGIES INC
- KEY STRATEGIC DEVELOPMENTS
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT – SEQUENCING REAGENTS
TABLE 2: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 3: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 5: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 7: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 8: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 9: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 10: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
TABLE 11: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
TABLE 12: LEADING PLAYERS OPERATING IN NORTH AMERICA SEQUENCING REAGENTS MARKET
TABLE 13: LIST OF MERGERS & ACQUISITIONS
TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 15: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 16: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER’S FIVE FORCES ANALYSIS
FIGURE 3: OPPORTUNITY MATRIX
FIGURE 4: VENDOR LANDSCAPE
FIGURE 5: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, IN 2020
FIGURE 6: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 7: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 8: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 9: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, IN 2020
FIGURE 10: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 13: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 14: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 15: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, IN 2020
FIGURE 16: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 17: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 18: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 19: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 20: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 21: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY END-USER, IN 2020
FIGURE 22: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 23: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 24: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 25: NORTH AMERICA SEQUENCING REAGENTS MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
FIGURE 26: NORTH AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
FIGURE 27: UNITED STATES SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
FIGURE 28: CANADA SEQUENCING REAGENTS MARKET, 2021-2028 (IN $ MILLION)
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- MARKET SIZE & ESTIMATES
- KEY GROWTH ENABLERS
- KEY CHALLENGE
- KEY PLAYERS
- COUNTRY ANALYSIS
- UNITED STATES
- CANADA
- NORTH AMERICA
- MARKET BY TECHNOLOGY
- NEXT-GENERATION SEQUENCING
- SANGER SEQUENCING
- THIRD-GENERATION SEQUENCING
- MARKET BY REAGENT TYPE
- SEQUENCING KITS
- CONTROL KITS
- LIBRARY KITS
- TEMPLATE KITS
- OTHER REAGENT TYPES
- MARKET BY APPLICATION
- ONCOLOGY
- CLINICAL INVESTIGATION
- AGRI GENOMICS AND FORENSICS
- REPRODUCTIVE HEALTH
- OTHER APPLICATIONS
- MARKET BY END-USER
- RESEARCH INSTITUTES
- HOSPITALS AND CLINICS
- PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
- OTHER END-USERS
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.